1. Home
  2. SHOP vs NVS Comparison

SHOP vs NVS Comparison

Compare SHOP & NVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shopify Inc.

SHOP

Shopify Inc.

HOLD

Current Price

$115.98

Market Cap

164.5B

Sector

Technology

ML Signal

HOLD

Logo Novartis AG

NVS

Novartis AG

HOLD

Current Price

$155.20

Market Cap

286.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SHOP
NVS
Founded
2004
1895
Country
Canada
Switzerland
Employees
N/A
75267
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
164.5B
286.5B
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
SHOP
NVS
Price
$115.98
$155.20
Analyst Decision
Buy
Hold
Analyst Count
33
5
Target Price
$164.44
$144.00
AVG Volume (30 Days)
8.6M
2.0M
Earning Date
05-05-2026
04-28-2026
Dividend Yield
N/A
2.16%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$11,556,000,000.00
N/A
Revenue This Year
$29.34
$2.30
Revenue Next Year
$23.77
$5.27
P/E Ratio
N/A
$23.13
Revenue Growth
30.14
N/A
52 Week Low
$94.00
$112.34
52 Week High
$182.19
$170.46

Technical Indicators

Market Signals
Indicator
SHOP
NVS
Relative Strength Index (RSI) 57.00 60.27
Support Level $108.12 $149.49
Resistance Level $128.90 $158.80
Average True Range (ATR) 5.21 2.45
MACD 0.60 0.61
Stochastic Oscillator 92.11 89.24

Price Performance

Historical Comparison
SHOP
NVS

About SHOP Shopify Inc.

Shopify offers an e-commerce platform primarily to small and medium-size businesses. The firm has two segments. The subscription solutions segment allows Shopify merchants to conduct e-commerce on a variety of platforms, including the company's website, physical stores, pop-up stores, kiosks, social networks (Facebook), and Amazon. The merchant solutions segment offers add-on products for the platform that facilitate e-commerce and include Shopify Payments, Shopify Shipping, and Shopify Capital.

About NVS Novartis AG

Novartis develops and manufactures innovative drugs. Key areas of drug development are oncology, immunology, neuroscience, respiratory, and cardiovascular, renal, and metabolic. It also has an established medicines business, which includes off-patent franchises. The company sells its products globally, with the United States constituting close to one-third of total revenue.

Share on Social Networks: